Following the end of the initial acceptance period of the offer, Capio controls 67,841,018 shares and votes in GHP, corresponding to approximately 96.6 percent of the total number of shares shares and votes in GHP 
As a result, all conditions for completion of the offer have been satisfied and Capio has declared the offer unconditional. The settlement of the Offer will begin on or around May 2, 2022. Capio intends to initiate a compulsory acquisition procedure in accordance with Swedish regulations.
I am delighted by the positive outcome of this project and would like to welcome the GHP team to the Ramsay Santé Group. This ambitious project brings together the expertise of GHP Specialty Care with 300,000 patients visit per year in 23 facilities in Sweden and 1 in Denmark with the one of Capio in the Nordics. This will consolidate the Group's positions for the benefit of the patients by offering an additional coverage to that of the activities already held. The complementarity of the two structures should enable us to achieve €6 million in synergies in the medium term.
 Based on 70,256,949 issued shares in GHP.
After the acquisition of the Capio Group in 2018, Ramsay Santé has become the leading European provider of comprehensive healthcare services. The group now has 36,000 employees and works with nearly 8,600 private practitioners.
Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 facilities.
In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres.
The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS).
The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.